Europe Radiopharmaceuticals Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Imaging Centers, Academic and Research Centers, and Others)

No. of Pages: 157    |    Report Code: TIPRE00025879    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Radiopharmaceuticals Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Radiopharmaceuticals Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Radiopharmaceuticals Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Rising Prevalence of Chronic Diseases
  • 5.1.2 Growing Number of Clinical Trials in Targeted Therapy
5.2 Market Opportunities
  • 5.2.1 High Growth Potential in Developing Countries
5.3 Future Trends
  • 5.3.1 Short Shelf-Life of Radiopharmaceuticals
5.4 Impact of Drivers and Restraints

6. Europe Radiopharmaceuticals Market Regional Analysis

6.1 Europe Radiopharmaceuticals Market Overview
6.2 Europe Radiopharmaceuticals Market Revenue 2019-2028 (US$ Million)
6.3 Europe Radiopharmaceuticals Market Forecast Analysis

7. Europe Radiopharmaceuticals Market Analysis – by Type

7.1 Diagnostic Nuclear Medicine
  • 7.1.1 Overview
  • 7.1.2 Diagnostic Nuclear Medicine: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Therapeutic Nuclear Medicine
  • 7.2.1 Overview
  • 7.2.2 Therapeutic Nuclear Medicine: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Radiopharmaceuticals Market Analysis – by Application

8.1 Oncology
  • 8.1.1 Overview
  • 8.1.2 Oncology: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
  • 8.2.1 Overview
  • 8.2.2 Cardiology: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Neurology
  • 8.3.1 Overview
  • 8.3.2 Neurology: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Radiopharmaceuticals Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Neurology: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Imaging Centers
  • 9.2.1 Overview
  • 9.2.2 Neurology: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic and Research Centers
  • 9.3.1 Overview
  • 9.3.2 Neurology: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Radiopharmaceuticals Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Radiopharmaceuticals Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Radiopharmaceuticals Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.1.2 UK: Europe Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.1.3 UK: Europe Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.2 Germany: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.2.2 Germany: Europe Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.2.3 Germany: Europe Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.3 France: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.3.2 France: Europe Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.3.3 France: Europe Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.4 Russia: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.4.2 Russia: Europe Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.4.3 Russia: Europe Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.5 Italy: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.5.2 Italy: Europe Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.5.3 Italy: Europe Radiopharmaceuticals Market Breakdown, by End User
  • 10.1.1.6 Rest of Europe: Europe Radiopharmaceuticals Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Radiopharmaceuticals Market Breakdown, by Type
    • 10.1.1.6.2 Rest of Europe: Europe Radiopharmaceuticals Market Breakdown, by Application
    • 10.1.1.6.3 Rest of Europe: Europe Radiopharmaceuticals Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Radiopharmaceuticals Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Advanced Accelerator Applications
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bayer AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Bracco Imaging S.p.A
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Cardinal Health Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Curium
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 ECZACIBAI MONROL NUCLEAR PRODUCTS CO.
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 GENERAL ELECTRIC
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Lantheus Medical Imaging, Inc.
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Nordion
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 NTP RADIOISOTOPES
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. Advanced Accelerator Applications
  2. Bayer AG
  3. Bracco Imaging S.p.A
  4. Cardinal Health Inc
  5. Curium
  6. ECZACIBA?I MONROL NUCLEAR PRODUCTS CO.
  7. GENERAL ELECTRIC
  8. Lantheus Medical Imaging, Inc.
  9. Nordion
  10. NTP RADIOISOTOPES  
europe-radiopharmaceuticals-market